Copyright Reports & Markets. All rights reserved.

Global Intravenous (IV) Ibuprofen Sales Market Report 2021

Request for Sample of this report
Buy now

1 Intravenous (IV) Ibuprofen Market Overview

  • 1.1 Intravenous (IV) Ibuprofen Product Scope
  • 1.2 Intravenous (IV) Ibuprofen Segment by Type
    • 1.2.1 Global Intravenous (IV) Ibuprofen Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 100 mg Dose
    • 1.2.3 200 mg Dose
    • 1.2.4 400 mg Dose
    • 1.2.5 800 mg Dose
  • 1.3 Intravenous (IV) Ibuprofen Segment by Application
    • 1.3.1 Global Intravenous (IV) Ibuprofen Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Pain
    • 1.3.3 Fever
    • 1.3.4 Inflammation
  • 1.4 Intravenous (IV) Ibuprofen Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Intravenous (IV) Ibuprofen Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Intravenous (IV) Ibuprofen Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Intravenous (IV) Ibuprofen Price Trends (2016-2027)

2 Intravenous (IV) Ibuprofen Estimates and Forecasts by Region

  • 2.1 Global Intravenous (IV) Ibuprofen Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Intravenous (IV) Ibuprofen Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Intravenous (IV) Ibuprofen Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Intravenous (IV) Ibuprofen Revenue Market Share by Region (2016-2021)
  • 2.3 Global Intravenous (IV) Ibuprofen Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Intravenous (IV) Ibuprofen Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Intravenous (IV) Ibuprofen Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Intravenous (IV) Ibuprofen Estimates and Projections (2016-2027)
    • 2.4.2 Europe Intravenous (IV) Ibuprofen Estimates and Projections (2016-2027)
    • 2.4.3 China Intravenous (IV) Ibuprofen Estimates and Projections (2016-2027)
    • 2.4.4 Japan Intravenous (IV) Ibuprofen Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Intravenous (IV) Ibuprofen Estimates and Projections (2016-2027)
    • 2.4.6 India Intravenous (IV) Ibuprofen Estimates and Projections (2016-2027)

3 Global Intravenous (IV) Ibuprofen Competition Landscape by Players

  • 3.1 Global Top Intravenous (IV) Ibuprofen Players by Sales (2016-2021)
  • 3.2 Global Top Intravenous (IV) Ibuprofen Players by Revenue (2016-2021)
  • 3.3 Global Intravenous (IV) Ibuprofen Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intravenous (IV) Ibuprofen as of 2020)
  • 3.4 Global Intravenous (IV) Ibuprofen Average Price by Company (2016-2021)
  • 3.5 Manufacturers Intravenous (IV) Ibuprofen Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Intravenous (IV) Ibuprofen Market Size by Type

  • 4.1 Global Intravenous (IV) Ibuprofen Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Intravenous (IV) Ibuprofen Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Intravenous (IV) Ibuprofen Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Intravenous (IV) Ibuprofen Price by Type (2016-2021)
  • 4.2 Global Intravenous (IV) Ibuprofen Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Intravenous (IV) Ibuprofen Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Intravenous (IV) Ibuprofen Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Intravenous (IV) Ibuprofen Price Forecast by Type (2022-2027)

5 Global Intravenous (IV) Ibuprofen Market Size by Application

  • 5.1 Global Intravenous (IV) Ibuprofen Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Intravenous (IV) Ibuprofen Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Intravenous (IV) Ibuprofen Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Intravenous (IV) Ibuprofen Price by Application (2016-2021)
  • 5.2 Global Intravenous (IV) Ibuprofen Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Intravenous (IV) Ibuprofen Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Intravenous (IV) Ibuprofen Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Intravenous (IV) Ibuprofen Price Forecast by Application (2022-2027)

6 North America Intravenous (IV) Ibuprofen Market Facts & Figures

  • 6.1 North America Intravenous (IV) Ibuprofen Sales by Company
    • 6.1.1 North America Intravenous (IV) Ibuprofen Sales by Company (2016-2021)
    • 6.1.2 North America Intravenous (IV) Ibuprofen Revenue by Company (2016-2021)
  • 6.2 North America Intravenous (IV) Ibuprofen Sales Breakdown by Type
    • 6.2.1 North America Intravenous (IV) Ibuprofen Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Intravenous (IV) Ibuprofen Sales Breakdown by Type (2022-2027)
  • 6.3 North America Intravenous (IV) Ibuprofen Sales Breakdown by Application
    • 6.3.1 North America Intravenous (IV) Ibuprofen Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Intravenous (IV) Ibuprofen Sales Breakdown by Application (2022-2027)

7 Europe Intravenous (IV) Ibuprofen Market Facts & Figures

  • 7.1 Europe Intravenous (IV) Ibuprofen Sales by Company
    • 7.1.1 Europe Intravenous (IV) Ibuprofen Sales by Company (2016-2021)
    • 7.1.2 Europe Intravenous (IV) Ibuprofen Revenue by Company (2016-2021)
  • 7.2 Europe Intravenous (IV) Ibuprofen Sales Breakdown by Type
    • 7.2.1 Europe Intravenous (IV) Ibuprofen Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Intravenous (IV) Ibuprofen Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Intravenous (IV) Ibuprofen Sales Breakdown by Application
    • 7.3.1 Europe 136 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 136 Sales Breakdown by Application (2022-2027)

8 China Intravenous (IV) Ibuprofen Market Facts & Figures

  • 8.1 China Intravenous (IV) Ibuprofen Sales by Company
    • 8.1.1 China Intravenous (IV) Ibuprofen Sales by Company (2016-2021)
    • 8.1.2 China Intravenous (IV) Ibuprofen Revenue by Company (2016-2021)
  • 8.2 China Intravenous (IV) Ibuprofen Sales Breakdown by Type
    • 8.2.1 China Intravenous (IV) Ibuprofen Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Intravenous (IV) Ibuprofen Sales Breakdown by Type (2022-2027)
  • 8.3 China Intravenous (IV) Ibuprofen Sales Breakdown by Application
    • 8.3.1 China 244 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 244 Sales Breakdown by Application (2022-2027)

9 Japan Intravenous (IV) Ibuprofen Market Facts & Figures

  • 9.1 Japan Intravenous (IV) Ibuprofen Sales by Company
    • 9.1.1 Japan Intravenous (IV) Ibuprofen Sales by Company (2016-2021)
    • 9.1.2 Japan Intravenous (IV) Ibuprofen Revenue by Company (2016-2021)
  • 9.2 Japan Intravenous (IV) Ibuprofen Sales Breakdown by Type
    • 9.2.1 Japan Intravenous (IV) Ibuprofen Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Intravenous (IV) Ibuprofen Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Intravenous (IV) Ibuprofen Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Intravenous (IV) Ibuprofen Market Facts & Figures

  • 10.1 Southeast Asia Intravenous (IV) Ibuprofen Sales by Company
    • 10.1.1 Southeast Asia Intravenous (IV) Ibuprofen Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Intravenous (IV) Ibuprofen Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Intravenous (IV) Ibuprofen Sales Breakdown by Type
    • 10.2.1 Southeast Asia Intravenous (IV) Ibuprofen Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Intravenous (IV) Ibuprofen Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Intravenous (IV) Ibuprofen Sales Breakdown by Application
    • 10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027)

11 India Intravenous (IV) Ibuprofen Market Facts & Figures

  • 11.1 India Intravenous (IV) Ibuprofen Sales by Company
    • 11.1.1 India Intravenous (IV) Ibuprofen Sales by Company (2016-2021)
    • 11.1.2 India Intravenous (IV) Ibuprofen Revenue by Company (2016-2021)
  • 11.2 India Intravenous (IV) Ibuprofen Sales Breakdown by Type
    • 11.2.1 India Intravenous (IV) Ibuprofen Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Intravenous (IV) Ibuprofen Sales Breakdown by Type (2022-2027)
  • 11.3 India Intravenous (IV) Ibuprofen Sales Breakdown by Application
    • 11.3.1 India Intravenous (IV) Ibuprofen Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Intravenous (IV) Ibuprofen Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Intravenous (IV) Ibuprofen Business

  • 12.1 Cumberland Pharmaceuticals
    • 12.1.1 Cumberland Pharmaceuticals Corporation Information
    • 12.1.2 Cumberland Pharmaceuticals Business Overview
    • 12.1.3 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Products Offered
    • 12.1.5 Cumberland Pharmaceuticals Recent Development
  • 12.2 Alveda Pharmaceuticals
    • 12.2.1 Alveda Pharmaceuticals Corporation Information
    • 12.2.2 Alveda Pharmaceuticals Business Overview
    • 12.2.3 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Products Offered
    • 12.2.5 Alveda Pharmaceuticals Recent Development
  • 12.3 CSL Limited
    • 12.3.1 CSL Limited Corporation Information
    • 12.3.2 CSL Limited Business Overview
    • 12.3.3 CSL Limited Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 CSL Limited Intravenous (IV) Ibuprofen Products Offered
    • 12.3.5 CSL Limited Recent Development
  • 12.4 Sandor Medicaids
    • 12.4.1 Sandor Medicaids Corporation Information
    • 12.4.2 Sandor Medicaids Business Overview
    • 12.4.3 Sandor Medicaids Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Sandor Medicaids Intravenous (IV) Ibuprofen Products Offered
    • 12.4.5 Sandor Medicaids Recent Development
  • 12.5 PT. Soho Industri Pharmasi
    • 12.5.1 PT. Soho Industri Pharmasi Corporation Information
    • 12.5.2 PT. Soho Industri Pharmasi Business Overview
    • 12.5.3 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Products Offered
    • 12.5.5 PT. Soho Industri Pharmasi Recent Development
  • 12.6 Germin MED
    • 12.6.1 Germin MED Corporation Information
    • 12.6.2 Germin MED Business Overview
    • 12.6.3 Germin MED Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Germin MED Intravenous (IV) Ibuprofen Products Offered
    • 12.6.5 Germin MED Recent Development
  • 12.7 Grifols
    • 12.7.1 Grifols Corporation Information
    • 12.7.2 Grifols Business Overview
    • 12.7.3 Grifols Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Grifols Intravenous (IV) Ibuprofen Products Offered
    • 12.7.5 Grifols Recent Development
  • 12.8 Gloria Pharmaceuticals
    • 12.8.1 Gloria Pharmaceuticals Corporation Information
    • 12.8.2 Gloria Pharmaceuticals Business Overview
    • 12.8.3 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Products Offered
    • 12.8.5 Gloria Pharmaceuticals Recent Development
  • 12.9 Al Nabeel International
    • 12.9.1 Al Nabeel International Corporation Information
    • 12.9.2 Al Nabeel International Business Overview
    • 12.9.3 Al Nabeel International Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Al Nabeel International Intravenous (IV) Ibuprofen Products Offered
    • 12.9.5 Al Nabeel International Recent Development
  • 12.10 Laboratorios Valmorca
    • 12.10.1 Laboratorios Valmorca Corporation Information
    • 12.10.2 Laboratorios Valmorca Business Overview
    • 12.10.3 Laboratorios Valmorca Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Laboratorios Valmorca Intravenous (IV) Ibuprofen Products Offered
    • 12.10.5 Laboratorios Valmorca Recent Development

13 Intravenous (IV) Ibuprofen Manufacturing Cost Analysis

  • 13.1 Intravenous (IV) Ibuprofen Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Intravenous (IV) Ibuprofen
  • 13.4 Intravenous (IV) Ibuprofen Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Intravenous (IV) Ibuprofen Distributors List
  • 14.3 Intravenous (IV) Ibuprofen Customers

15 Market Dynamics

  • 15.1 Intravenous (IV) Ibuprofen Market Trends
  • 15.2 Intravenous (IV) Ibuprofen Drivers
  • 15.3 Intravenous (IV) Ibuprofen Market Challenges
  • 15.4 Intravenous (IV) Ibuprofen Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness.

    Market Analysis and Insights: Global Intravenous (IV) Ibuprofen Market
    The global Intravenous (IV) Ibuprofen market was valued at US$ 8103.3 in 2020 and will reach US$ 15400 million by the end of 2027, growing at a CAGR of 11.3% during 2022-2027.

    Global Intravenous (IV) Ibuprofen Scope and Market Size
    The global Intravenous (IV) Ibuprofen market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Intravenous (IV) Ibuprofen market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    100 mg Dose
    200 mg Dose
    400 mg Dose
    800 mg Dose

    Segment by Application
    Pain
    Fever
    Inflammation

    The Intravenous (IV) Ibuprofen market is analysed and market size information is provided by regions (countries). Segment by Application, the Intravenous (IV) Ibuprofen market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    Cumberland Pharmaceuticals
    Alveda Pharmaceuticals
    CSL Limited
    Sandor Medicaids
    PT. Soho Industri Pharmasi
    Germin MED
    Grifols
    Gloria Pharmaceuticals
    Al Nabeel International
    Laboratorios Valmorca

    Buy now